Whether independent relationships between white coat effects (office minus day (office-day blood pressure (BP))) and organ damage or arterial stiffness may be explained by associations with an attenuated nocturnal BP dipping, has not been determined.
It is well established that ambulatory blood pressure (BP) values are superior to office BP values in predicting cardiovascular outcomes. These effects have been attributed in part to either inaccurate office BP measurement or to white coat effects (increased office BP compared with day BP). In this regard, although white coat effects have been ascribed to an excessive sympathetic activitation, 1 whether this translates into adverse cardiovascular effects has not been resolved. Meta-analyses 2, 3 have demonstrated that an increased office but normal out-of-office BP predicts cardiovascular outcomes to a similar extent as that of sustained normotension (normal in and out-of-office BP). Furthermore, some studies have failed to demonstrate a relationship between isolated increases in office BP and organ damage. [4] [5] [6] In contrast, several studies have suggested that isolated increases in office BP predict cardiovascular outcomes 7, 8 and are associated with end-organ damage. [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] Moreover, the difference between office and day BP, an index of white coat effects, is strongly associated with organ damage and arterial stiffness, 19, 20 and this effect is equally as strong in normotensive subjects as it is in hypertensive subjects and is independent of ambulatory BP. 20 Although discrepancies between studies assessing the impact of white coat hypertension or effects on cardiovascular damage have not been explained, the considerable evidence to support these relationships [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] cannot be ignored. An appropriate explanation for the relationship between white coat effects and cardiovascular damage independent of ambulatory BP is nevertheless still forthcoming.
White coat BP effects are related to an attenuated decrease in nocturnal BP (BP dipping), 21 a change that has also been associated with an excess sympathetic nervous system activation. 22 Importantly, a blunted or reverse dipping pattern is associated with cardiovascular outcomes independent of 24-hour BP and a number of confounders in several populations. [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] It is therefore possible that the relationship between white coat effects and cardiovascular damage may be attributed to the adverse effects of attenuated nocturnal BP dipping. However, in large meta-analyses, the role of nocturnal BP dipping or nocturnal BP independent of day BP as predictors of cardiovascular damage has been questioned. 33, 34 Thus, in this study we aimed to evaluate whether office minus day (office-day) BP is inversely related to BP dipping and whether this relationship may in part explain the independent association between office-day BP and left ventricular mass index (LVMI) or arterial stiffness. 19, 20 
METHODS

Study group
This study was conducted according to the principles outlined in the Helsinki Declaration. The Committee for Research on Human Subjects of the University of the Witwatersrand approved the protocol (approval number: M02-04-72; renewed as M07-04-69 and M12-04-108). Participants gave informed, written consent. The study design has been described previously. [35] [36] [37] [38] Briefly, families of black African descent (Nguni and Sotho chiefdoms) with siblings aged >16 years were randomly recruited from the South West Township (SOWETO) of Johannesburg, South Africa. Of the 1,191 participants recruited, 750 participants had 24-hour ambulatory BP monitoring that met European Society of Hypertension guidelines (>14 and >7 readings for the computation of day and night means, respectively). 39 Of these participants, 662 had carotid-femoral (aortic) pulse wave velocity (PWV), an index of arterial stiffness, and 463 had echocardiography.
Clinical, demographic, and anthropometric measurements
A standardized questionnaire was administered to obtain demographic and clinical data. 20, 35, 36 Height and weight were measured using standard approaches, and participants were identified as being overweight if their body mass index was ≥25 kg/m 2 and obese if their body mass index was ≥30 kg/m 2 . Blood tests of renal function, liver function, blood glucose, hematological parameters, and percentage glycated hemoglobin (HbA 1C ) (Roche Diagnostics, Mannheim, Germany) were performed. Diabetes mellitus or abnormal blood glucose control was defined as the use of insulin or oral hypoglycemic agents or an HbA 1C value >6.1%. 40 
Blood pressure
High-quality conventional office BP measurements were obtained by 1 trained nurse according to guidelines using a standard mercury sphygmomanometer, as previously described. 20 The nurse was of the same ethnic origins (black African) as the participants and had previously lived in SOWETO. Ambulatory 24-hour, day, and night BP were determined using SpaceLabs monitors (model 90207, Redmond, Washington, USA) as previously described. 20 The quality of the office BP measurements and the number of 24-hour, day, and night BP recordings has previously been reported. 20 Hypertension was defined as a mean BP ≥140/90 mm Hg or the use of antihypertensive medication. A normal day BP was considered to be <135/85 mm Hg. White coat effects were identified from the difference between office and day BP, and white coat hypertension (isolated office hypertension) was defined as an office BP >140/90 mm Hg and a day BP of <135/85 mm Hg. 38 
Pulse wave velocity
Carotid-femoral (aortic) PWV was determined using applanation tonometry and SphygmoCor software as previously described. 20, [35] [36] [37] After participants had rested for 15 minutes in the supine position, arterial waveforms, together with a simultaneous electrocardiogram recording, were recorded at the carotid and femoral pulse by applanation tonometry during an 8-second period using a high-fidelity SPC-301 micromanometer (Millar Instrument, Houston, TX) interfaced with a computer employing SphygmoCor, version 6.21 software (AtCor Medical, West Ryde, New South Wales, Australia). Recordings were discarded when the systolic or diastolic variability of consecutive waveforms exceeded 5% or when the amplitude of the pulse wave signal was <80 mV. The time delay in the pulse waves between the carotid and femoral sites was determined using the R wave of electrocardiograph recordings as a fiducial point. Pulse transit time was taken as the average of 10 consecutive beats. Distances from the suprasternal notch to the carotid sampling site (distance A) and from the suprasternal notch to the femoral artery (distance B) were measured. Pulse wave velocity distance was calculated as distance B minus distance A. Aortic PWV was calculated as distance (meters) divided by transit time (seconds).
Echocardiography
Two-dimensional targeted M-mode echocardiography was employed to determine short axis dimension measurements, as previously described 20, 35, 36 and analyzed according to the American Society of Echocardiography convention. 41 All measurements were recorded and analyzed offline by experienced investigators (CDL and AJW) who were unaware of the clinical data of the participants. Left ventricular mass was determined using a standard formula 42 and indexed (LVMI) to height 2.7 . The intra-and interobserver variability have previously been described. 20 Left ventricular hypertrophy was identified as an LVMI > 51 g/m 2.7 . 43 
Data analysis
For database management and statistical analysis, SAS software, version 9.1 (SAS Institute, Cary, NC) was employed. Data are shown as mean ± SD or mean ± SEM. Means and proportions were compared by the large-sample z test and the χ 2 statistic, respectively. Relationships were determined using multivariable regression analysis with appropriate confounders included in each model. Categorical analysis (relationships between white coat hypertension and LVMI or PWV) was not performed because this approach assumes that neither normotensive subjects nor hypertensive subjects have a white coat effect. To determine the changes in LVMI or PWV per millimeter of mercury of office-day systolic BP (SBP) attributed to indexes of nocturnal SBP dipping or nocturnal BP per se, we employed product of coefficient mediation analysis. 44 Adjustments were made for the impact of day, night, day-night BP or percentage night/day BP, age, sex, body weight (for LVMI) or body mass index (for PWV), the presence of diabetes mellitus or an HbA1c >6.1%, pulse rate, treatment for hypertension (in all participants), regular tobacco use, and regular alcohol intake. When assessing relationships with PWV, office mean arterial pressure (distending pressure) was also included as an adjustor. To determine probability values, further adjustments for nonindependence of family members was performed using nonlinear regression analysis (mixed procedure as defined in the SAS package). To ensure that relationships with target organ changes occurred independent of the use of antihypertensive therapy, sensitivity analysis was conducted in untreated participants only.
RESULTS
General characteristics of participants
Because it was more frequently difficult to obtain highquality ambulatory 24-hour BP recordings in obese participants, those without 24-hour measurements that met with prespecified quality control criteria (n = 441) were more obese (percentage obese = 49.2; P < 0.001), and these participants had a trend for a higher office SBP (P < 0.05). In general, more women than men participated, and a high prevalence of obesity and hypertension was noted (Table 1) . Those participants with PWV or LVMI measurements had similar characteristics as the whole group (data not shown). Eighteen percent of participants had white coat hypertension (increased office but normal day BP) ( Table 1 ). In addition, 19% of participants had an abnormal nocturnal decline in BP (nondippers) as defined from the lower 95% confidence intervals of day-night BP noted in 158 healthy participants without hypertension or diabetes mellitus (no medication and HbA1c <6.1%), with a body mass index <30 kg/m 2 , who did not smoke or consume alcohol regularly, and with normal blood results ( Table 1) .
Relationship between white coat effects and BP dipping
In unadjusted and multivariable-adjusted (including for day BP) analysis, office-day systolic or diastolic BP was inversely related to day-night or directly related to percentage night/day SBP and diastolic BP (BP dipping) ( Table 2) . Moreover, office-day SBP was directly correlated with night SBP (r = 0.14; P = 0.0001), an effect which also persisted with adjustments for day BP (partial r = 0.22; P < 0.0001).
Relationship between BP dipping or nocturnal BP and LVMI or PWV
In multivariable-adjusted analyses (including adjustments for day (Table 3) or 24-hour (Supplementary Table S1 ) BP, neither decreases in SBP at night nor percentage systolic night/day BP (BP dipping) were independently associated with LVMI. However, in multivariable-adjusted analyses that included adjustments for day BP (Table 3) but not for 24-hour BP (Supplementary Table S1 ), decreases in SBP at night or percentage systolic night/day BP were independently associated with PWV. Neither decreases in diastolic BP at night nor percentage diastolic night/day BP (BP dipping) were associated with LVMI or PWV (data not shown). With adjustments for day SBP, night SBP was also not independently associated with LVMI, but an independent relationship was noted between night SBP and PWV (Table 4) .
Contribution of BP dipping or nocturnal BP to relationships between white coat effects and LVMI or PWV
Office-day SBP was independently associated with LVMI and PWV (Table 5 ) and these relationships persisted with adjustments for either day (LVMI: partial r = 0.15, P < 0.01; PWV: partial r = 0.22; P < 0.0001) or 24-hour (LVMI: partial r = 0.14, P < 0.01; PWV: partial r = 0.21, P < 0.0001) SBP. Moreover, in product of coefficient mediation analysis with appropriate adjustments, neither 24-hour nor day SBP contributed toward the relationship between white coat effects and LVMI or PWV (Table 6 ). Importantly, the relationships between white coat effects and LVMI or PWV were unaffected by adjustments for either SBP dipping (daynight or percentage night/day SBP) or night SBP (Table 5) . Moreover, on mediation analysis with multivariable adjustments, indexes of neither SBP dipping nor nocturnal SBP contributed toward the impact of office-day SBP on either LVMI or PWV (Table 6 ).
DISCUSSIOn
The main findings of this study are as follows: In a group of African descent in South Africa, although white coat effects, as indexed by office-day BP, were independently associated with an attenuated nocturnal BP decline, neither BP dipping nor night BP contributed toward the independent relationships between white coat effects and either LVMI or aortic PWV.
Although prior studies have demonstrated a strong and independent relationship between white coat effects as indexed by office-day BP and an attenuated decline in BP at night, 21 to the best of our knowledge our study is the first to show that this relationship cannot account for the previously described impact of white coat effects on organ damage or arterial stiffness. 19, 20 In this regard, in this study, although we were able to show that office-day BP was related to indexes of nocturnal decreases in BP and night BP, adjustments for indexes of nocturnal BP dipping or night BP failed to modify the independent relationships between office-day BP and either LVMI or PWV. Moreover, in product of coefficient mediation analysis, indexes of neither nocturnal BP dipping nor night BP contributed independently toward the impact of white coat effects on LVMI or PWV. Thus, our study suggests that modifying the timing of antihypertensive therapy so that dosing is changed from morning to evening to ensure adequate decreases in nocturnal BP (chronotherapy) is unlikely to modify the relationships between white coat effects and organ damage or arterial stiffness.
Given that reduced BP dipping and nocturnal BP have previously been demonstrated in several populations to have an adverse prognostic impact [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] and that groups of African ancestry have generally been described to have attenuated nocturnal BP dipping, changes associated with end-organ damage, 45 the question arises as to why indexes of BP dipping were not associated with organ damage or arterial stiffness beyond 24-hour BP in our study population? Importantly, the role of BP dipping as an independent predictor of cardiovascular damage is controversial. In 23,856 hypertensive subjects and 9,641 individuals from a variety of populations, dipping status, and the night/day ratio has previously been shown to add little prognostic information beyond 24-hour BP. 33 Furthermore, in the International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes (IDACO) analysis conducted in 7458 individuals enrolled in population studies worldwide, although the night/day ratio predicted cardiovascular mortality, this ratio lost its prognostic significance in untreated participants. 34 Only intervention studies specifically targeting BP dipping or nocturnal BP will resolve the issue of the Abbreviations: CI, confidence interval; SEM, standard error of the mean. a Adjustments are for age, sex, body weight (for LVMI), body mass index (for PWV), the presence of diabetes mellitus or glycated hemoglobin >6.1%, pulse rate, treatment for hypertension (in all participants and hypertensives), regular tobacco use, regular alcohol intake and office mean arterial pressure (for PWV only).
b Standardized. c Further adjusted for nonindependence of family members. Abbreviations: CI, confidence interval; SEM, standard error of the mean. a Adjustments are for age, sex, body weight (for LVMI), body mass index (for PWV), the presence of diabetes mellitus or glycated hemoglobin >6.1%, pulse rate, treatment for hypertension (in all participants and hypertensives), regular tobacco use, regular alcohol intake and office mean arterial pressure (for PWV only).
b Standardized. c Further adjusted for nonindependence of family members.
role of BP dipping and night BP beyond day BP in contributing toward adverse cardiovascular effects. An important limitation of our study is that we did not evaluate whether the inability to decrease BP at night in some people may occur as a consequence of disturbed sleep patterns. In this regard, this may have explained the lack of relationship between BP dipping and LVMI or PWV because perceived sleep deprivation attenuates the relationship between nocturnal BP dipping and cardiovascular outcomes. 46 However, this does not explain how in the our study white coat effects were closely associated with both an attenuated BP dipping and LVMI and PWV, but the relationship Abbreviation: SEM, standard error of the mean. a Adjustments are for age, sex, body weight (for LVMI), body mass index (for PWV), the presence of diabetes mellitus or glycated haemoglobin >6.1%, pulse rate, treatment for hypertension, regular tobacco use, regular alcohol intake and office mean arterial pressure (for PWV only). *P < 0.05, **P < 0.0001 vs. effect of office-day SBP. between white coat effects and LVMI and PWV could not be accounted for by an attenuated BP dipping. The results of our study raise the question as to the possible mechanisms that may explain the relationship between white coat effects and organ damage or arterial stiffness. Our study suggests that an attenuated nocturnal decrease in BP cannot account for these relationships. Importantly, the results of this and prior 20, 47, 48 studies suggest that these relationships cannot be explained by the adverse actions of BP per se. Indeed, these relationships occur independent of 24-hour, 20 day, 20 and night (this study) BP, and although antihypertensive therapy may reduce white coat effects, this is not associated with on-treatment reductions in target organ changes. 47, 48 The possible non-BP-related adverse actions mediated by white coat effects could be explained by an excess sympathetic activation. 1 In this regard, an increase in general sympathetic activity 49 and cardiac adrenergic spillover 50 occurs in LV hypertrophy, and these changes may account for increases in LVMI or alternative organ changes independent of BP.
The limitations of our study include the cross-sectional design, which precludes conclusions being drawn regarding cause and effect. Longitudinal studies and intervention studies specifically targeting isolated increases in office BP are therefore required. However, until the mechanism of this effect has been clearly identified and specific therapy targeting this mechanism has been developed, such a study will not be forthcoming. Second, this study was conducted in 1 ethnic group, a group previously demonstrated to have high prevalence of white coat effects. 38 Further studies with high-quality office BP measurements conducted by a single nurse or technicianobserver or with measurements well standardized across sites are therefore required in alternative ethnic groups with a high prevalence of white coat responses to address this issue.
In conclusion, in this study we show that in a group of African ancestry in South Africa, although white coat effects, as indexed by office-day BP, are independently associated with an attenuated nocturnal BP decline, decreases in BP dipping do not explain the strong and independent relationships between white coat effects and target organ changes and arterial stiffness. These data suggest that modifying the time of taking antihypertensive therapy from morning to night dosing to ensure adequate decreases in nocturnal BP is unlikely to reduce the cardiovascular damage associated with white coat effects. Further studies are required to evaluate the mechanisms that explain the relationship between white coat effects and end-organ changes and arterial stiffness.
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